In situ cancer vaccination: an IL-12 defective vector/replication-competent herpes simplex virus combination induces local and systemic antitumor activity (Q45756276)
Jump to navigation
Jump to search
scientific article published on May 1, 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | In situ cancer vaccination: an IL-12 defective vector/replication-competent herpes simplex virus combination induces local and systemic antitumor activity |
scientific article published on May 1, 1998 |
Statements
1 reference
In situ cancer vaccination: an IL-12 defective vector/replication-competent herpes simplex virus combination induces local and systemic antitumor activity (English)
1 reference
M. Toda
R. L. Martuza
H. Kojima
1 May 1998
1 reference
1 reference
160
1 reference
9
1 reference
4457-4464
1 reference